# Kyowa Hakko Bio Co. Ltd. – FDA Inspection, Sep 15, 2017

Source: https://www.keypedia.com/records/fda_inspections/kyowa-hakko-bio-co-ltd/274c4990-3600-44d7-bc36-7b1584231e09
Source feed: FDA_Inspections

> FDA inspection 1026240 of Kyowa Hakko Bio Co. Ltd., September 15, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1026240
- Company Name: Kyowa Hakko Bio Co. Ltd.
- Inspection Date: 2017-09-15
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1113169 - 2019-11-08
- FDA Inspection 873176 - 2014-03-14
- FDA Inspection 675346 - 2010-07-02

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/marcus-f-yambot/a2266014-ae7e-4d64-aeba-a8cfb873f100)

Company: https://www.keypedia.com/companies/kyowa-hakko-bio-co-ltd/09d5ed98-2ceb-4216-8fc1-51327eb2f42a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c